NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment

Recruiting N/A Interventional Study
Neurodevelopmental Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
24 Weeks – 34 Weeks
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
124 (estimated)
Sponsor
St. Justine's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without manipulation with olfactory stimulation with breast milk in the incubator/bed both combined with appropriate light and noise levels to promote neurodevelopment preterm infants.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for preterm infants: * born between 24 and 33 6/7 weeks GA; * ready for SSC Inclusion criteria for mothers and fathers: * agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant; * mothers express breas…
Contacts

Marilyn Aita, Ph.D.

514-343-6111

marilyn.aita@umontreal.ca

CONTACT

Kate St-Arneault, Ph.D (cand.)

kate.st-arneault.hsj@ssss.gouv.qc.ca

CONTACT